Research & Development
Pharmaceutical Product Development & Manufacturing
CURE Pharmaceutical is a Full-Scale Drug Manufacturing Company
Wellness products grounded in science
DEA Schedule 1
Specific release profiles
Better patient experience
Protection from degradation
during manufacturing and throughout shelf life.
CUREfilm® products are about the size of a postage stamp and can deliver therapeutic actives through the oral mucosal tissue, sublingually or buccally – between the cheek and gum – or more traditionally via the gastrointestinal tract. Oral transmucosal drug delivery is a non-invasive route reserved for pharmaceutical drugs that allows for absorption directly into the vascularized tissue in the mouth, bypassing the hepatic first pass effect. This leads to reduced drug exposure and can offer a rapid onset of action.
Active ingredients in the CUREfilm® dose form can be either pre-solubilized within its matrix or encapsulated, or both for more effective absorption and/or sustained release. As oral thin films quickly dissolve, no water is required for their administration, improving patient compliance – especially among the elderly, children, and in conditions where patients have difficulty in swallowing.